Skip to search formSkip to main contentSkip to account menu

XomaZyme-MEL

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

XomaZyme

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors.
From 1987 to 1991, 26 patients with CML and a median age of 31 years received allogeneic BMT from a partially mismatched related… 
1994
1994
XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
Patients who receive bone marrow transplants from unrelated donors have a high incidence of graft-versus-host disease (GVHD). If… 
1989
1989
T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or…
The aim of this study was to compare the extent of in vitro T cell depletion and recovery of hematopoietic progenitor cells… 
1989
1989
A new approach to the prevention of graft-versus-host disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)